Histopathological Analysis of Renal Biopsies With Dynamic Full-field Optical Coherence Tomography, a Comparison to Conventional Histopathological Findings for the Diagnosis of Either Acute Kidney Injury or Chronic Kidney Disease in Routine Practices (NEPHROCT)

Launched by CENTRE HOSPITALIER WILLIAM MOREY - CHALON SUR SAÔNE · Feb 14, 2023

Keywords

ClinConnect Summary

This clinical trial, called NEPHROCT, is exploring a new way to examine kidney biopsies using a technique called dynamic full-field optical coherence tomography (OCT). This method aims to improve the speed and accuracy of diagnosing conditions like acute kidney injury and chronic kidney disease, which are serious health issues affecting the kidneys. By comparing this new technique to traditional methods, the researchers hope to make kidney diagnostics more efficient and effective.

To participate in this trial, individuals must be over 18 years old and have either suspected acute kidney injury or chronic kidney disease that requires a biopsy. It's important to note that if a patient cannot undergo the new imaging method during the biopsy, they won't be eligible for the study. Participants in this trial will have their kidney biopsies examined using the new technique, which may help doctors better understand their kidney health and guide treatment options. The trial is currently looking for volunteers, and everyone's contribution could help improve kidney care for many patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients \> 18 years of age with suspected acute kidney injury requiring biopsy in the nephrology department
• • patients \> 18 years of age with suspected chronic kidney disease requiring biopsy in the nephrology department
• Exclusion Criteria:
• • inability to perform dynamic full-field optical coherence tomography observation at the moment of kidney biopsy